NeoGenomics (NASDAQ:NEO) Price Target Lowered to $28.00 at BTIG Research
NeoGenomics (NASDAQ:NEO – Get Rating) had its target price cut by research analysts at BTIG Research from $35.00 to $28.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. BTIG Research’s target price would suggest a potential upside of 57.39% from the company’s […]